What Lab Tests Are Elevated With Alcoholism?

Learn which measurable blood markers indicate chronic alcohol consumption and the resulting systemic physical stress.

Chronic heavy drinking leaves fingerprints across a wide range of blood and urine tests, from liver enzymes and blood cell size to iron stores, lipids, and specialized alcohol metabolites. No single lab value reliably confirms alcoholism on its own, but a pattern of abnormalities across several markers gives clinicians a much clearer picture. Some of these tests reflect organ damage already underway, while others detect the chemical traces of alcohol itself, and the distinction matters both for diagnosis and for understanding what your body is going through.

Liver Enzymes and the AST-to-ALT Ratio

Gamma-glutamyl transferase, usually listed as GGT on a lab panel, is one of the most commonly elevated markers in people who drink heavily. GGT helps maintain levels of glutathione, the body’s main internal antioxidant, which gets depleted during alcohol metabolism. When the liver is processing a lot of alcohol, GGT production ramps up to compensate for the resulting oxidative stress. The rise in GGT after alcohol consumption tracks with the increase in reactive oxygen species that both chronic and acute drinking produce. GGT is sensitive, meaning it catches a lot of drinkers, but it is not very specific. Obesity, certain medications, bile duct problems, and other liver diseases can push GGT up too.

The aminotransferases AST and ALT also rise with alcohol-related liver injury, but the ratio between them is often more telling than either value alone. In most other forms of liver disease, ALT runs higher than AST. Alcohol flips this pattern. Among patients with alcoholic cirrhosis, roughly 70% had an AST-to-ALT ratio of 2 or higher, while only about 8% had a ratio at or below 1. Patients with alcoholic hepatitis and cirrhosis together had an even more dramatically skewed mean ratio of about 2.7, compared to about 1.5 in those with alcoholic hepatitis alone. This flipped ratio has a physiological basis: alcohol damages mitochondria in liver cells, which releases extra AST into the bloodstream, while also depleting the vitamin B6 that ALT production depends on. The higher the ratio climbs, the more advanced the liver disease tends to be, rather than just reflecting heavier drinking per se.

Carbohydrate-Deficient Transferrin

Carbohydrate-deficient transferrin, or CDT, is one of the few lab markers specifically designed to detect sustained heavy drinking rather than organ damage. Transferrin is a protein that carries iron in the blood, and it normally has sugar molecules (carbohydrate chains) attached to it. Chronic alcohol intake interferes with how the liver attaches those sugars, producing an abnormal, “carbohydrate-deficient” version that accumulates after roughly two or more weeks of heavy consumption. CDT is widely used to confirm recent heavy drinking, especially alongside other liver-associated enzymes.

The main advantage of CDT is its high specificity: when it’s elevated, the cause is usually alcohol. The main disadvantage is its relatively low sensitivity. The test works best in people consuming large amounts daily, generally above about 60 grams of ethanol per day (roughly four to five standard drinks), and it tends to miss lighter-but-still-problematic drinking patterns. One study found that only about half of confirmed heavy drinkers had a CDT level above the diagnostic threshold. Women, people with higher body weight, and patients with cirrhosis were more likely to have a falsely normal result. Pregnancy can also shift transferrin glycosylation enough to produce false-positive CDT results, meaning clinicians may need to adjust the cutoff for pregnant women.

Phosphatidylethanol, EtG, and Other Direct Metabolites

A newer generation of biomarkers detects molecules the body produces only when alcohol is present, making them highly specific. Phosphatidylethanol (PEth) is formed when ethanol reacts with phospholipids in cell membranes. It has emerged as a marker of unhealthy alcohol use because it accumulates in red blood cells during drinking and clears slowly once someone stops. In one study of patients entering alcohol detox, every single person tested positive for PEth on admission. PEth concentrations correlate well with self-reported drinking levels, and undetectable PEth matches with abstinence or very light consumption.

Ethyl glucuronide (EtG) and ethyl sulfate (EtS) are minor metabolites of ethanol that can be detected in urine and hair. In urine, EtG can remain positive for up to about 90 hours after drinking, making it useful for short-term monitoring in treatment settings. At moderate and high alcohol doses, urinary EtG remained detectable in all participants 12 hours after drinking stopped. By 48 hours, detection rates dropped below 40% even at higher doses. For a longer look-back window, both EtG and fatty acid ethyl esters (FAEE) can be measured in hair, where they become durably deposited and can reflect months of drinking history.

These direct metabolites are increasingly used in clinical, legal, and transplant settings because they answer a narrow but important question: has this person consumed alcohol recently? They say nothing about liver damage or organ health, which is why they complement rather than replace the traditional enzyme markers.

Red Blood Cell Size and Macrocytosis

One of the quieter signs of heavy drinking shows up on a routine complete blood count. Mean corpuscular volume (MCV) measures the average size of red blood cells, and chronic alcohol use tends to make them larger than normal, a condition called macrocytosis. Among patients with alcohol-related liver disease, about 70% had macrocytosis, compared to roughly 23% of patients with liver disease from other causes. When MCV climbed above 100 femtoliters, the gap widened further: half of alcoholic liver disease patients but only about 3% of non-alcoholic liver disease patients reached that level.

The effect appears to be dose-related. Even moderate drinkers showed slightly higher MCV values compared to abstainers, and in people whose drinking habits were tracked over time, MCV rose and fell in parallel with alcohol intake. In one study of 300 patients with an MCV at or above 100 femtoliters, alcohol abuse was the single largest diagnostic category, accounting for roughly 80% of men and about a third of women. Alcohol enlarges red blood cells partly through a direct toxic effect on developing cells in the bone marrow and partly through the folate and B12 deficiencies that heavy drinking promotes. MCV drops slowly after abstinence because red blood cells live about 120 days, so it can take months to normalize.

Triglycerides, HDL, and Uric Acid

A standard lipid panel can carry hints of heavy drinking. Alcohol stimulates the liver to produce large VLDL particles, which are the main carriers of triglycerides. This is the primary driver of the elevated triglycerides seen in chronic heavy drinkers. At the same time, alcohol raises HDL cholesterol in a dose-dependent way by speeding up the production of the proteins (apolipoproteins A-I and A-II) that HDL particles are built from. The combination of high triglycerides and high HDL on a lipid panel is not diagnostic by itself, but it fits the alcohol picture and can make a clinician look more carefully.

Uric acid levels also tend to climb with heavy drinking, through a couple of routes. Alcohol metabolism generates excess NADH, which pushes more pyruvate toward lactate. The resulting lactate competes with uric acid for excretion through the kidneys, so uric acid backs up in the blood. On top of that, alcohol speeds up the breakdown of ATP (the cell’s energy currency), and the degradation products feed into purine pathways that produce more uric acid. This is one reason heavy drinkers are at higher risk for gout.

Iron Overload and Ferritin

Elevated ferritin is common in heavy drinkers and can be dramatically high. Ferritin is the main storage form of iron, and alcohol disrupts iron regulation from multiple angles. Ethanol exposure suppresses hepcidin, the liver’s master iron-regulating hormone, which leads to increased iron absorption from the gut. At the same time, alcohol upregulates transferrin receptor expression in liver cells, pulling more iron into the liver. The excess iron deposits in the liver and can worsen alcohol-induced liver injury, accelerating disease progression.

The clinical problem with sky-high ferritin in a drinker is that it can mimic hereditary hemochromatosis, a genetic condition of true iron overload. Even transferrin saturation above 45%, the usual screening threshold for hereditary iron disorders, has low specificity and often turns up in people whose real problem is alcohol-related liver disease and inflammation. Ferritin is also an acute-phase reactant, meaning it rises with inflammation from any cause. In alcoholic liver disease, the combination of genuine iron loading and inflammatory release makes ferritin a sensitive but potentially confusing marker.

Pancreatic Enzymes

Alcohol is the leading cause of both acute and chronic pancreatitis in many countries, and the pancreatic enzymes amylase and lipase are the lab markers that flag it. Among chronic alcoholics without abdominal symptoms, about 14% had elevated serum amylase and lipase levels, reflecting subclinical pancreatic stress. In patients with full-blown alcoholic acute pancreatitis, pancreatic amylase was elevated in about 94% of cases, while lipase reached 100% sensitivity.

Lipase is generally the more useful of the two for distinguishing true pancreatitis from simple alcohol-related enzyme elevation. In one study comparing alcoholics with confirmed pancreatitis against asymptomatic heavy drinkers, about 45% of pancreatitis patients had amylase levels that overlapped with the range seen in drinkers who did not have pancreatitis. Lipase did not overlap at all: every single pancreatitis patient had a lipase level above the highest value found in asymptomatic drinkers. If you drink heavily and your doctor is checking for pancreatitis, lipase is the test that matters most.

Creatine Kinase and Muscle Damage

Alcohol does not only affect the liver and pancreas. Skeletal muscle takes a hit too, and creatine kinase (CK) is the lab value that shows it. In a study of patients admitted after recent heavy alcohol consumption, about 36% had elevated CK levels without any evidence of a heart attack. The pattern was different from cardiac injury: CK values were already elevated on arrival and trended downward over 24 hours, rather than showing the rising-then-falling curve typical of a heart attack.

In more extreme cases, alcohol can trigger rhabdomyolysis, a dangerous breakdown of muscle tissue that floods the bloodstream with CK and myoglobin. One case report documented a patient whose CK soared from about 2,900 to over 11,000 units per liter within a day of admission, accompanied by dark brown urine from the released muscle protein. Rhabdomyolysis can damage the kidneys if not treated with aggressive fluid replacement. It often happens after a binge where someone passes out in one position for hours, compressing muscle tissue, but direct alcohol toxicity to muscle cells plays a role too.

Immunoglobulin A

A lesser-known marker that clinicians sometimes notice is elevated immunoglobulin A (IgA), one of the body’s antibodies. About 70% of patients with alcohol-related liver disease have increased serum IgA levels. Patients with alcoholic liver disease also show IgA deposits along the liver’s sinusoids, the tiny blood channels inside the organ. The ratio of IgA to IgG tends to be highest in alcoholic liver disease compared to other forms of fatty liver disease, which can help distinguish the cause when imaging alone is ambiguous. The likely mechanism involves alcohol increasing gut permeability, which lets bacterial products cross into the bloodstream and triggers IgA production as a mucosal immune response.

Bilirubin and Clotting Time

When the liver is severely damaged, its synthetic functions start to fail, and two markers reflect this directly. Total bilirubin rises because the liver can no longer process and excrete it efficiently, and prothrombin time (PT) lengthens because the liver is not making enough clotting factors. In alcoholic hepatitis, increases in both bilirubin and PT are associated with poor outcomes and are included in the scoring systems doctors use to judge disease severity and decide on steroid treatment. Unlike GGT or CDT, these markers say nothing about whether someone is drinking; they signal that the liver is in serious trouble regardless of cause. A drinker with normal bilirubin and PT likely has not yet progressed to severe hepatitis or cirrhosis.

Folate, B12, and Homocysteine

Alcohol interferes with the absorption and metabolism of B vitamins, particularly folate and B12. Even a relatively short period of regular drinking can push these levels down. In a controlled crossover study of healthy volunteers, two weeks of moderate alcohol consumption led to measurable drops in both serum folate and B12 concentrations, accompanied by a rise in plasma homocysteine. Homocysteine is an amino acid that normally gets recycled using folate and B12 as cofactors. When those vitamins are depleted, homocysteine accumulates. Elevated homocysteine is linked to cardiovascular risk and may contribute to the nerve damage that chronic drinkers sometimes develop. This B vitamin disruption also feeds back into the macrocytosis described earlier, since folate is required for normal red blood cell production.

Alcoholic Ketoacidosis

In a specific but dangerous scenario, heavy drinkers who stop eating for a period while continuing to drink (or shortly after stopping) can develop alcoholic ketoacidosis. This shows up as a high anion gap metabolic acidosis, meaning the blood becomes abnormally acidic because of a buildup of ketone bodies, particularly beta-hydroxybutyrate. Electrolyte disturbances often accompany it, including low magnesium, low potassium, and low phosphate, all of which alcohol depletes through poor intake, vomiting, and increased kidney excretion. These electrolyte abnormalities are not unique to alcoholism, but their clustering in someone with a known drinking history is a recognizable pattern in emergency departments.

Why Combining Markers Works Better

No single lab test is both sensitive and specific enough to reliably identify heavy drinking on its own. Each test has blind spots: GGT is sensitive but fires on many non-alcohol causes, CDT is specific but misses a lot of drinkers, MCV changes slowly, and the direct metabolites mainly capture recent intake. Combining markers narrows those gaps. A calculated combination of GGT and CDT (called GGT-CDT) reached 90% sensitivity for correctly identifying heavy drinkers, outperforming CDT alone at 63%, GGT alone at 58%, MCV at 45%, and AST or ALT at under 50%. The combined marker performed similarly well in drinkers with and without existing liver disease, which is relevant because liver disease itself distorts many of the individual markers.

In clinical practice, doctors rarely rely on one abnormal value. They look for a constellation: elevated GGT with a flipped AST-to-ALT ratio, large red blood cells, high ferritin, rising uric acid, and perhaps a positive PEth or EtG. When several of these line up in the same patient, the picture becomes hard to explain by anything other than heavy alcohol use, even if no single test is definitive.

When These Tests Mislead

Virtually every marker discussed above can be thrown off by something other than alcohol. Elevated GGT shows up in obesity, nonalcoholic fatty liver disease, and with certain medications. A high AST-to-ALT ratio can occur in advanced liver fibrosis from any cause. Macrocytosis accompanies hypothyroidism, vitamin B12 deficiency from any source (including pernicious anemia or a vegan diet), and certain medications like methotrexate. Ferritin spikes in infections, autoimmune disease, and malignancy. CK rises with intense exercise. Elevated triglycerides come with metabolic syndrome, diabetes, and high-carbohydrate diets.

The direct ethanol metabolites (PEth, EtG, EtS) are the most specific, but even they have limitations. EtG in urine can yield positive results from incidental exposures like alcohol-based hand sanitizer or certain mouthwashes at the lowest cutoff thresholds, though this is less of an issue at the higher cutoffs commonly used in clinical monitoring. CDT false positives, as mentioned, can occur in pregnancy and in certain rare genetic variants of transferrin. Hair EtG testing can reflect months of drinking history, but cosmetic hair treatments may affect concentrations.

Perhaps the most important caveat is that normal lab values do not rule out alcohol use disorder. A person can drink heavily for years with relatively normal liver enzymes if their liver happens to be resilient, and many of the indirect markers only become clearly abnormal once organ damage has started. Direct metabolite testing fills part of this gap, but it captures a window of days to weeks, not a lifetime pattern. The best diagnostic tool for alcoholism remains a thorough clinical history, and lab tests serve as supporting evidence, not verdicts.